$INGR

Ingredion appoints Diego Reynoso as new chief financial officer

Ingredion has named Diego Reynoso as its new chief financial officer, starting October 1, 2026. He will oversee finance, strategy, and capital allocation, reporting to CEO Jim Zallie. Reynoso previously served as CFO at Boston Beer Company and held roles at Tyson Foods and Constellation Brands.

Original reporting
Published Aug 24, 2026, 8:26 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 24, 2026, 9:07 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ingredion appoints Diego Reynoso as new chief financial officer — source image
Decision brief

The 30-second read

$INGRNeutralLow
01

Why it matters

The CFO hire is a standard corporate update with limited immediate market impact but could affect long‑term strategic execution.

02

Market read

Exec appointment news; low‑to‑moderate relevance for traders.

03

What to watch

Reynoso's experience at Boston Beer and consumer brands may bring fresh perspectives to Ingredion's portfolio.

Relevance 7/10Novelty 6/10Timing: effective Oct 1 2026

Background

Ingredion is a US‑listed food ingredients company (ticker INGR) focusing on growth through acquisitions and portfolio transformation.

Company-level read

Ticker impact

$INGRNeutralMedium confidence
Context

Ingredion announced the appointment of Diego Reynoso as CFO effective 1 Oct 2026.

Expected impact

Limited short‑term impact; potential modest upside if investors view the hire positively.

Evidence & confidence

Executive appointments are typically low‑impact unless tied to major strategic shifts.

Market effects

May signal continued focus on growth and integration within the food ingredients sector.

Minimal regional effect; primarily relevant to US investors.

Limited global relevance beyond Ingredion's shareholder base.

Counterpoint

The appointment could be a distraction if the new CFO fails to deliver on integration goals.

Key entities

  • Diego Reynoso

    New Chief Financial Officer of Ingredion.

  • Jim Zallie

    Chairman, President and CEO of Ingredion.

Related articles

$DARMedAI 8/10

A Look Back at Ingredients, Flavors & Fragrances Stocks’ Q2 Earnings: Darling Ingredients (NYSE:DAR) Vs The Rest Of The Pack

Ingredients, flavors, and fragrances stocks reported mixed Q2 earnings, with revenues missing estimates by 2.4%. Darling Ingredients (DAR) reported $1.72B revenue, up 16.4% YoY, beating estimates. Archer-Daniels-Midland (ADM) reported $22.68B revenue, up 7.2% YoY, outperforming estimates. International Flavors & Fragrances (IFF) reported $1.95B revenue, down 29.3% YoY, missing estimates. Ingredion (INGR) reported $1.85B revenue, flat YoY, topping estimates. Bunge Global (BG) reported $24.04B rev

$INGRMedAI 8/10

Ingredion (INGR) Q2 2026 Earnings Call Transcript

Ingredion (NYSE:INGR) reported Q2 2026 net sales of $1.85B (+1%) and adjusted operating income of $258M (-5%). Adjusted EPS was $2.82. Management cited Argo facility issues, Mexico currency headwinds, and rising tapioca costs. It reaffirmed 2026 adjusted EPS guidance of $10.30 to $10.90 and expects Tate & Lyle acquisition synergies of $130M run-rate by 2030.

$INGRMedAI 8/10

Ingredion (INGR) Q2 2026 Earnings Call Transcript

Ingredion (INGR) reported Q2 2026 net sales of $1.85 billion (+1%) and adjusted operating income of $258 million (-5%). Adjusted EPS was $2.82. Results reflected volume growth in Texture & Healthful Solutions, but currency headwinds in Mexico and Argo facility issues. Full-year 2026 adjusted EPS guidance is $10.30 to $10.90; cash from ops $700m to $800m. Tate & Lyle acquisition pending.

$INGRMed

Ingredion (INGR) Reaffirmed Its 2026 Guidance, Is The Stock Fully Valued?

Ingredion (INGR) reported Q2 2026 results and reaffirmed its full-year outlook. For Q3 2026, it expects net sales up low single digits. Full-year 2026 sales are projected flat to up low single digits, with reported EPS of $9.15 to $9.75. It expects 2026 operating income down low double digits. A DCF fair value is cited at $88.23 versus a $104.33 close.

$INGRMedAI 8/10

Ingredion-Tate & Lyle $3.6bn deal cleared in Brazil

Brazil’s competition authority cleared Ingredion’s proposed $3.6 billion acquisition of Tate & Lyle under a fast-track review. The deal was notified July 20 and approved after the agency’s assessment. The clearance removes a regulatory hurdle for the transaction, which could affect both companies’ deal-related outlook.

Ingredion appoints Diego Reynoso as new chief financial officer — alphai